Earnings call briefThird-quarter 2026
Amgen AMGN
Amgen now expects 2026 non-GAAP other expense of $2 billion to $2.1 billion
Amgen also said it does not expect a step-down in 2027 operating margin compared with its 2026 guidance.
GetSignal
Free on iOS and Android
On its third-quarter call, Chief Financial Officer Thomas J. Dittrich said Amgen expects other revenue of approximately $1.9 billion for the full year and a non-GAAP tax rate of 15% to 16.5%. Amgen also said it expects a meaningful sequential increase in fourth-quarter operating expenses.
Quotes from the call
“We now anticipate non-GAAP other income and expense to be in the range of $2 billion to $2.1 billion of expense in 2026.”
Key facts from the call
- Expected 2026 non-GAAP other income and expense
- $2 billion to $2.1 billion of expense
- Expected 2026 other revenue
- approximately $1.9 billion
- Expected 2026 non-GAAP tax rate
- 15% to 16.5%
Source: Amgen's third-quarter 2026 earnings call, November 3, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.